Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

<< < Results 101 - 200 of 2610 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 6468738 Hyperargininemia: the rat as a model for the human disease and the comparative response to enzyme replacement therapy with free arginase and arginase-loaded erythrocytes in vivo. diagnostic usage
ongoing research
therapeutic application
unassigned
2
4
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 6729810 A successful trial of enzyme replacement therapy in a case of argininemia. causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 6796772 Urinary pyrimidine excretion in arginase deficiency. causal interaction
diagnostic usage
therapeutic application
unassigned
3
2
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 6820432 Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet. therapeutic application
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 7159597 Polyamine dependence of Chinese hamster ovary cells in serum-free culture is due to deficient arginase activity. ongoing research
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 7361766 Properties of fetal and adult red blood cell arginase: a possible prenatal diagnostic test for arginase deficiency. causal interaction
diagnostic usage
ongoing research
unassigned
1
2
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 7389092 Fluorometric micromethod for determination of arginase activity in dried blood spots on filter paper. causal interaction
diagnostic usage
therapeutic application
unassigned
3
3
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 7717428 Prenatal diagnosis of the urea cycle diseases: a survey of the European cases. causal interaction
diagnostic usage
unassigned
2
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 7967487 Arginase deficiency presenting with convulsions. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 8127062 Arginase deficiency in two brothers. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 8454280 Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 8474825 Arginase deficiency presenting as cerebral palsy. causal interaction
diagnostic usage
therapeutic application
unassigned
4
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 8777806 [A case of complicated form of hereditary spastic paraplegia associated with hypoplasia of the corpus callosum and cataracta] causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 8902193 Loss of function mutations in conserved regions of the human arginase I gene. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 9131018 Delivery of cytosolic liver arginase into the mitochondrial matrix space: a possible novel site for gene replacement therapy. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 9295913 [Proposal for a diet treatment in arginase deficiency] therapeutic application
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 9590022 [Arginase deficiency] unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 9686347 The human arginases and arginase deficiency. ongoing research
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 9762606 Adult-onset arginase deficiency. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 10771848 Arginase deficiency. causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 10947208 Arginase deficiency presenting with cerebral oedema and failure to thrive. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 11148548 The nutritional management of urea cycle disorders. causal interaction
diagnostic usage
unassigned
1
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 11154268 Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. causal interaction
therapeutic application
unassigned
2
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 11746885 Analysis of amino acids as formamidene butyl esters by electrospray ionization tandem mass spectrometry. diagnostic usage
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 12052859 Mouse model for human arginase deficiency. causal interaction
diagnostic usage
ongoing research
unassigned
4
3
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 12640389 Arginase deficiency with lethal neonatal expression: evidence for the glutamine hypothesis of cerebral edema. causal interaction
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 14605507 Prenatal diagnosis for arginase deficiency: a case study. causal interaction
diagnostic usage
therapeutic application
unassigned
4
4
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15164414 Genetic approach to prenatal diagnosis in urea cycle defects. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15465784 Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15546957 Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15565656 Prenatal diagnosis for arginase deficiency by second-trimester fetal erythrocyte arginase assay and first-trimester ARG1 mutation analysis. causal interaction
diagnostic usage
therapeutic application
unassigned
4
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15694174 Hyperargininemia due to liver arginase deficiency. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 15798789 Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl. causal interaction
diagnostic usage
unassigned
1
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 16233191 Different missense mutations in PDR1 and PDR3 genes from clotrimazole-resistant sake yeast are responsible for pleiotropic drug resistance and improved fermentative activity. causal interaction
diagnostic usage
unassigned
3
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 16602094 Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. causal interaction
diagnostic usage
unassigned
4
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 16963300 A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation. therapeutic application
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 17098461 Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 17513443 Orotic acid excretion and arginine metabolism. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 17513445 Biomarkers identified in inborn errors for lysine, arginine, and ornithine. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 17997338 Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 18950360 Anesthesia in a patient with arginase deficiency: implications and management. causal interaction
therapeutic application
unassigned
3
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 19052914 Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 19367256 Short-term Correction of Arginase Deficiency in a Neonatal Murine Model With a Helper-dependent Adenoviral Vector. ongoing research
therapeutic application
unassigned
1
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 19486531 Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 19936428 A novel mutation in ARG1 gene is responsible for arginase deficiency in an Asian family. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 20004862 Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts. causal interaction
diagnostic usage
ongoing research
unassigned
4
3
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 20304692 Creatine metabolism and the urea cycle. causal interaction
diagnostic usage
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 20372170 Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 20456883 A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations. diagnostic usage
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 21229317 Neonatal cholestasis: an uncommon presentation of hyperargininemia. causal interaction
therapeutic application
unassigned
3
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 21585399 Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. ongoing research
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 21802329 Arginase I deficiency: Severe infantile presentation with hyperammonemia: More common than reported? causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 22760543 Long-term Survival of the Juvenile Lethal Arginase-deficient Mouse With AAV Gene Therapy. causal interaction
ongoing research
therapeutic application
unassigned
3
1
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 22964440 Arginase deficiency with new phenotype and a novel mutation: contemporary summary. causal interaction
diagnostic usage
ongoing research
unassigned
4
2
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 22971419 Recurrent unexplained hyperammonemia in an adolescent with arginase deficiency. causal interaction
ongoing research
therapeutic application
unassigned
1
2
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 23388701 AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. causal interaction
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 23859858 Five novel mutations in ARG1 gene in Chinese patients of argininemia. causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 23920045 Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
3
1
1
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 24224027 Inducible arginase 1 deficiency in mice leads to hyperargininemia and altered amino acid metabolism. causal interaction
ongoing research
unassigned
4
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 24465919 Arginase-1 Deficiency Regulates Arginine Concentrations and NOS2-Mediated NO Production during Endotoxemia. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 24814679 Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 24888478 Myocyte-mediated Arginase Expression Controls Hyperargininemia but not Hyperammonemia in Arginase-deficient Mice. causal interaction
ongoing research
unassigned
2
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 25474440 Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 25611620 Anesthetic management of a patient with arginase deficiency undergoing liver transplantation. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 25938595 Strategies to rescue the consequences of inducible arginase-1 deficiency in mice. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 26123990 Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 26310552 [Seven patients of argininemia with spastic tetraplegia as the first and major symptom and prenatal diagnosis of two fetuses with high risk]. unassigned 0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 26358771 Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
4
4
4
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 26467175 Arginase-1 deficiency. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27038030 Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency. causal interaction
diagnostic usage
therapeutic application
unassigned
4
3
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27215558 Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27335400 Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27570396 Late onset arginase deficiency presenting with encephalopathy and midbrain hyperintensity. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27663197 Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study. causal interaction
unassigned
2
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27761413 Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency. causal interaction
diagnostic usage
unassigned
2
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27898091 Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells. causal interaction
therapeutic application
unassigned
2
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 27998825 Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 28515179 Arginase-2 mediates renal ischemia-reperfusion injury. causal interaction
ongoing research
unassigned
1
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 28566761 Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 28659245 Newborn screening for hyperargininemia due to arginase 1 deficiency. causal interaction
diagnostic usage
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 28747341 Arginase1 Deficiency in Monocytes/Macrophages Upregulates Inducible Nitric Oxide Synthase To Promote Cutaneous Contact Hypersensitivity. causal interaction
ongoing research
unassigned
4
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29187023 Biopsy-proven Hepatocellular Carcinoma in a 53-year-old Woman With Arginase Deficiency. causal interaction
therapeutic application
unassigned
2
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29423830 Biochemical markers and neuropsychological functioning in distal urea cycle disorders. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29478971 Kidney Mass Reduction Leads to l-Arginine Metabolism-Dependent Blood Pressure Increase in Mice. causal interaction
diagnostic usage
unassigned
1
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29724658 Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice. causal interaction
ongoing research
therapeutic application
unassigned
3
4
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29948653 Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 29961498 "Cerebral Palsy" in a Patient With Arginase Deficiency. causal interaction
diagnostic usage
unassigned
3
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 30294546 The first pediatric case of glucagon receptor defect due to biallelic mutations in GCGR is identified by newborn screening of elevated arginine. therapeutic application
unassigned
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 30670878 Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders. causal interaction
diagnostic usage
unassigned
4
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 30671984 A new metabolic disorder in human cationic amino acid transporter-2 that mimics arginase 1 deficiency in newborn screening. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 31484827 Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development. causal interaction
ongoing research
therapeutic application
unassigned
4
1
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 31501335 Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 31604595 Sodium phenylbutyrate improved the clinical state in an adult patient with arginase 1 deficiency. causal interaction
diagnostic usage
unassigned
2
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 31649772 Arginase Deficiency Presenting as Acute Encephalopathy. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
2
3
1
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 32025996 Anesthetic management of a pediatric patient with arginase-1 deficiency undergoing strabismus operation: a case report. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 32580855 Hyperargininemic Encephalopathy with Unique Clinical Presentation and Novel Genetic Mutations. causal interaction
ongoing research
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 32769929 A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia: A case report. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 32872442 Metabolic Serendipities of Expanded Newborn Screening. causal interaction
unassigned
3
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 33325055 Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. causal interaction
unassigned
4
0
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase deficiency 33542202 Novel ARG1 variants identified in a patient with arginase 1 deficiency. causal interaction
unassigned
1
0
<< < Results 101 - 200 of 2610 > >>